Post-Infectious Conditions Research

What this page covers

Some people do not recover as expected after an infection and keep symptoms for months. Researchers call these conditions post-infectious or "infection-associated chronic conditions". Long COVID is the largest and best-studied example, and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a related condition; one review notes similarities between long COVID and viral-onset illnesses such as ME/CFS. [1] This page is information only, not medical advice. It reports what research shows and where it stops, and it does not recommend any treatment. Labels such as established, mixed and insufficient evidence are explained in how we label evidence.

Definitions differ, so studies are not always comparable

The National Academies definition does not require laboratory confirmation or proof of the initial infection, partly because early tests were limited. [3] The term "infection-associated chronic condition" covers conditions triggered by viruses, bacteria, fungi or parasites, and the committee chose it so as not to imply conclusions about mechanism. [3]

What is known and not known

• Symptoms: WHO reports more than 200 different symptoms, with fatigue, breathlessness, muscle or joint pain and impaired sleep common. [2] It describes patterns that tend to occur together, including symptoms of post-exertional malaise and ME/CFS. [2]
• Cause: one trial report states that the pathogenesis of long COVID is unknown, and that viral persistence is among the leading hypotheses. [5] A review of the field says substantial progress has been made on its biology but there is no cure. [6] Treat any single-cause claim as insufficient evidence.
• ME/CFS: the NHS says the cause is unknown, there is no specific test, and diagnosis rests on symptoms and ruling out other conditions. [7]
• Who is affected: a meta-analysis of 41 studies (860,783 patients) found post-COVID condition associated with female sex (odds ratio 1.56), older age, higher BMI, smoking, other health conditions (2.48) and earlier hospitalization (2.37). Two vaccine doses were associated with lower risk (0.57). [8] These are observational associations, so they do not prove cause; see observational studies and confounding.

What trials have shown

How to read this: the first two were negative on their main goals. Improvement in every arm of the second trial shows why a comparison group matters. The review's positive findings are about managing symptoms and function. They do not show that those programs treat an underlying immune or viral cause. WHO says there is limited research on treatments and no large studies to show which are most effective, and that clinicians may offer symptom relief or rehabilitation. [2] The NHS says there is no cure for long COVID, but treatments can help ease symptoms. [4]

Immune markers: where the line is

Many studies compare blood immune measures in people with and without long COVID. A difference in a marker is a biomarker finding. It does not show what caused the illness, and it does not show that changing the marker would help. The National Academies recommended developing a standard protocol for screening and diagnosing long COVID, which means none is settled. [3] Be cautious with commercial "immune panels"; see unvalidated immune panels and the claim check on one biomarker as a complete immune assessment.

Research programs

The U.S. National Institutes of Health created the RECOVER Initiative to understand, diagnose, prevent and treat Long COVID across many types of studies. [11] A registered or recruiting trial is not evidence that a treatment works; see clinical-trial phases explained.